your partner in preclinical research

Latest Posts

> 2017 Oct

Acquisition of Urolead company.

Urosphere is pleased to announce its acquisition of Urolead company.

Read more

> 2017 Sep

Urosphere will be present at the International Continence Society 2017

Urosphere will present an oral communication at ICS (Florence, 12-15 september 2017)

Read more

> 2017 Mar

Urosphere will be present at the European Association of Urology congress 2017

Urosphere will present two posters at the 32st annual EAU congress (24-28 March 2017).     

Read more

> 2016 May

Urosphere presented two posters at ERA-EDTA congress

Urosphere presented two posters in collaboration with Solid Drug Development at the 53rd annual ERA-EDTA congress: Effect of JNK inhibitor in a rat model of renal ischemia-reperfusion injury (link) Effects of JNK inhibitor on puromycin aminonucleoside-induced nephropathy in rats (link) Please click on links next to the posters titles to see them.

Read more

> 2016 Feb

Urosphere will be present at the European Association of Urology congress 2016

Urosphere will be present at the International Continence Society 2017 will present two posters at the 31st annual EAU congress (13 March 2016 at 12:45 PM, room 14a): Immunotherapy to treat Bladder Painful Syndrome Development and validation of a clinically-relevant chronic model of Interstitial Cystitis / Bladder Painful Syndrome It will be a pleasure to meet you during the EAU congress. Don't hesitate to contact us.

Read more